Nirosen Vijiaratnam

13PUBLICATIONS
48CO-AUTHORS
Toxicology (incl. clinical toxicology)Medical biotechnology diagnostics (incl. biosensors)Epigenetics (incl. genome methylation and epigenomics)PharmacogenomicsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 29, 2025
Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs.

Evita Papathoma, Panagiota Tsitsi, Nirosen Vijiaratnam

|Oct 03, 2025
Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.

Ilham Y Abdi, Indulekha P Sudhakaran, Simona S Ghanem

|Apr 16, 2025
Intronic FGF14 GAA repeat expansions impact progression and survival in multiple system atrophy.

Viorica Chelban, David Pellerin, Nirosen Vijiaratnam

|Aug 22, 2024
Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early- to Mid-Stage Parkinson's Disease Modification Trials.

Nirosen Vijiaratnam, Christine Girges, Dilan Athauda

|Sep 04, 2023
Validation of a comorbidity questionnaire in patients with neurological disorders.

Nirosen Vijiaratnam, Shree Vadera, Katharina Lefringhausen

|Aug 03, 2023
How should we be using biomarkers in trials of disease modification in Parkinson's disease?

Nirosen Vijiaratnam, Thomas Foltynie

Pageof 3